Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
beta blocker
|
| gptkbp:ATCCode |
gptkb:C07AB03
|
| gptkbp:bioavailability |
50%
|
| gptkbp:CASNumber |
gptkb:29122-68-7
|
| gptkbp:contraindication |
asthma
heart block severe bradycardia |
| gptkbp:developedBy |
gptkb:ICI_Pharmaceuticals
|
| gptkbp:eliminationHalfLife |
6-7 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C14H22N2O3
|
| https://www.w3.org/2000/01/rdf-schema#label |
atenolol
|
| gptkbp:introducedIn |
1976
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
beta-1 adrenergic receptor antagonist
|
| gptkbp:metabolism |
minimal hepatic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
fatigue bradycardia cold extremities gastrointestinal disturbance |
| gptkbp:usedFor |
gptkb:arrhythmia
myocardial infarction hypertension angina pectoris |
| gptkbp:bfsParent |
gptkb:ICI_Pharmaceuticals
|
| gptkbp:bfsLayer |
5
|